RVNC accepts Crown’s $3.65/sh—tender_must_be_completed_by 2/7/25: https://investors.revance.com/investors/Press-Releases/news-details/2025/Crown-Laboratories-and-Revance-Amend-the-AR-Merger-Agreement-to-Increase-Offer-Price-to-3.65-per-Share-and-Extend-Existing-Tender-Offer/default.aspx If Crown does not obtain a majority of RVNC shares by 2/7/25, the buyout deal is terminated.